metaLead Therapeutics AG
PrivateLast Round
Seed
May 5, 2025
Total Funding Raised
$1.97M
Company Overview
metaLead Therapeutics AG is a biotechnology company that develops peptide-based therapeutics for the treatment of metal-related diseases and toxic metal accumulation disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
metaLead Therapeutics AG Comparables
Compare metaLead Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EmeraMed Limited | 77% | |
| Captura Biopharma | 76% | |
| Orphalan SA | 69% |
metaLead Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 5, 2025 | ||||
| Accelerator | Aug 18, 2024 | ||||
| Accelerator | Sep 1, 2023 | ||||
| Grant | Feb 15, 2023 |
metaLead Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| University of Zurich | Seed |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 155% MoM, reaching 1.6K.
- Nov 6, 2025
Monthly visitors increased 215% MoM.
metaLead Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about metaLead Therapeutics AG's valuation, stock price, and market status.
Is metaLead Therapeutics AG a public or private company?
metaLead Therapeutics AG is a private company.
What is the current stock price of metaLead Therapeutics AG?
metaLead Therapeutics AG is a private company with no public stock price. Caplight tracks metaLead Therapeutics AG's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is metaLead Therapeutics AG worth (valuation)?
Valuation information for metaLead Therapeutics AG is not publicly available.
Can I buy metaLead Therapeutics AG stock?
metaLead Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was metaLead Therapeutics AG's last funding round?
metaLead Therapeutics AG's most recent funding round was Seed on May 5, 2025.
Who are the main investors in metaLead Therapeutics AG?
Key investors in metaLead Therapeutics AG include University of Zurich.
Will metaLead Therapeutics AG IPO soon?
No public IPO plans have been announced for metaLead Therapeutics AG.
How can I track metaLead Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor metaLead Therapeutics AG's secondary market activity and sign up for updates.